Intensity Therapeutics, Inc.
INTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,671 | -$2,537 | -$3,347 | -$3,181 |
| Dep. & Amort. | $6 | $0 | $6 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $644 | $435 | $844 |
| Change in WC | -$193 | -$570 | $917 | -$229 |
| Other Non-Cash | $471 | $7 | $0 | -$102 |
| Operating Cash Flow | -$2,387 | -$2,456 | -$1,989 | -$2,668 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,238 | $3,743 | $328 | $3,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$524 |
| Financing Cash Flow | $7,238 | $3,743 | $328 | $2,476 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,851 | $1,287 | -$1,661 | -$192 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,216 | $929 | $2,590 | $2,782 |
| End Cash | $7,067 | $2,216 | $929 | $2,590 |
| Free Cash Flow | -$2,387 | -$2,456 | -$1,989 | -$2,668 |